Reply: The rationale for distinguishing RB-ILD and AMP.

Saved in:
Bibliographic Details
Title: Reply: The rationale for distinguishing RB-ILD and AMP.
Authors: Piciucchi S; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy piciucchi.sara@gmail.com.; Department of Radiology, GB Morgagni-Pierantoni Hospital, Forlì, Italy., Adegunsoye A; Department of Medicine, Section of Pulmonary and Critical Care, University of Chicago, Chicago, IL, USA., Travis WD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, and National Heart and Lung Institute, Imperial College London, London, UK., Wells AU; Royal Brompton Hospital and Imperial College, London, UK., Cooper WA; Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, Australia., Khor YH; Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, Australia.; Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Australia.; Institute for Breathing and Sleep, Heidelberg, Australia.; Faculty of Medicine, University of Melbourne, Melbourne, Australia., Wijsenbeek MS; Centre of Expertise for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC, Rotterdam, The Netherlands., Sharma A; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Hariri LP; Department of Pathology and Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Antoniou K; Department of Respiratory Medicine, Laboratory of Molecular and Cellular Pneumonology, School of Medicine, University of Crete, Heraklion, Greece., Borie R; Université Paris Cité, Inserm, PHERE, Hôpital Bichat, AP-HP, Service de Pneumologie A, Centre Constitutif du Centre de Référence des Maladies Pulmonaires Rares, FHU APOLLO, Paris, France., Fabre A; Histopathology Department, St Vincent's University Hospital, Dublin, Ireland.; University College Dublin School of Medicine, Dublin, Ireland., Inoue Y; Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.; Department of Internal Medicine, Osaka Anti-tuberculosis Association, Osaka Fukujuji Hospital, Osaka, Japan., Johannson KA; Department of Medicine and Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB, Canada., Johkoh T; Department of Radiology, Kansai Rosai Hospital, Amagasaki, Japan., Kawano-Dourado L; Hcor Research Institute, Hcor Hospital, Sao Paulo, Brazil.; MAGIC Evidence Ecosystem Foundation, Oslo, Norway.; Pulmonary Division, Heart Institute (InCor), University of Sao Paulo, Sao Paulo, Brazil., Kazerooni E; Departments of Radiology and Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Maher TM; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; National Heart and Lung Institute, Imperial College London, London, UK., Molyneaux PL; National Heart and Lung Institute, Imperial College London, London, UK.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK., Protti R; Patient representative, Vancouver, BC, Canada., Ravaglia C; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.; Pulmonology Unit, G.B. Morgagni Hospital, Forlì, Italy., Renzoni EA; National Heart and Lung Institute, Imperial College London, London, UK.; Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK., Saito-Koyama R; Department of Pathology, National Hospital Organization, Sendai Medical Center, Miyagi, Japan., Sverzellati N; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Scienze Radiologiche, University Hospital of Parma, Parma, Italy., Walsh SLF; Imperial College, London, UK.; Royal Brompton and Harefield Foundation Trust, London, UK.; Qureight Ltd, Cambridge, UK., Wolters PJ; Department of Medicine, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California, San Francisco, CA, USA., Yang SR; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ryerson CJ; Department of Medicine and Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.
Source: The European respiratory journal [Eur Respir J] 2025 Dec 04; Vol. 66 (6). Date of Electronic Publication: 2025 Dec 04 (Print Publication: 2025).
Publication Type: Letter; Comment
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1399-3003
DOI:10.1183/13993003.02029-2025